Don't overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers

The drug stock is higher over the past month while the S&P 500 has pulled back sharply.

KickT KickT
Apr 1, 2025 - 21:06
0 48
Don't overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers

Published Mon, Mar 31 20253:37 PM EDTUpdated An Hour Ago